• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction.

作者信息

Osborne D P, Katz D H

出版信息

J Immunol. 1977 Apr;118(4):1441-8.

PMID:15034
Abstract

The allogeneic effect has been employed as a potent immunopotentiator in preventing the growth of a murine plasmacytoma and prolonging host survival. Parental BALB/c spleen cells were passively transferred to (BALB/c x A/H)F1 hybrid mice, who were then given a highly lethal dose of MOPC 315 plasmacytoma, a tumor of BALB/c origin. The resultant graft-vs-host reaction protected the recipient mice against growth of the tumor and significantly prolonged survival. This phenomenon was dependent upon the dose of BALB/c lymphoid cells employed, the route of administration, and the time interval between lymphoid cell transfer and tumor inoculation. A wide range of lymphoid cell doses and time intervals were effective, and repeated doses of allogeneic cells provided better protection than a single dose.

摘要

相似文献

1
The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction.
J Immunol. 1977 Apr;118(4):1441-8.
2
The allogeneic effect on tumor growth. II. Suppression of both ascitic and solid MOPC 315 plasmacytoma by the graft-vs-host reaction, with pathologic correlation.同种异体对肿瘤生长的影响。II. 移植物抗宿主反应对腹水型和实体型MOPC 315浆细胞瘤的抑制作用及其病理相关性。
J Immunol. 1977 Apr;118(4):1449-55.
3
Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.荷瘤BALB/c小鼠经瘤内和腹腔注射美法仑治疗后对MOPC-315浆细胞瘤耐药性的发展。I. 联合化疗-免疫疗法增强体内排斥反应
J Natl Cancer Inst. 1982 Jun;68(6):963-9.
4
Protection against MOPC-315 plasmacytoma by immunization with C-type particle preparations.用C型颗粒制剂免疫对MOPC - 315浆细胞瘤的保护作用。
Cancer Res. 1978 Jan;38(1):223-5.
5
An experimental model for evaluation of factors in tumor escape from immunological attack.
Cancer Res. 1975 Mar;35(3):734-9.
6
[Effect of the cell dose on the development of 2 transplantable tumors in a syngeneic host].[细胞剂量对同基因宿主中两种可移植肿瘤生长的影响]
G Batteriol Virol Immunol. 1976 Jan-Jun;69(1-6):122-31.
7
Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.小鼠B细胞白血病(BCL1)中的异基因细胞疗法:1. 来自不同淋巴区室的未修饰和体外经重组白细胞介素-2激活的骨髓及淋巴细胞诱导的同种免疫介导的移植物抗白血病(GVL)效应。
Cytokines Cell Mol Ther. 1999 Sep;5(3):145-52.
8
Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.针对肿瘤特异性和宿主特异性同种异体抗原的自发及白细胞介素-2诱导的抗白血病和抗宿主效应。
J Immunol. 1993 Nov 1;151(9):4803-10.
9
Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.实验性异基因骨髓移植后通过给予白血病特异性T细胞清除残留疾病
Exp Hematol. 1998 Oct;26(11):1068-73.
10
Effect of subcutaneously administered 2,6,10,14-tetramethylpentadecane on plasmacytoma growth.皮下注射2,6,10,14-四甲基十五烷对浆细胞瘤生长的影响。
Cancer Res. 1980 Jul;40(7):2229-33.

引用本文的文献

1
Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.同种异体移植排斥反应及细胞介导免疫机制的分析。I. 肿瘤同种异体移植的加速排斥反应,脾脏细胞的细胞毒性未增强。
Immunology. 1980 May;40(1):67-76.
2
The presence of a tumour in F1 mice partially inhibits the GvH reaction following injection of parental spleen cells.在向F1代小鼠注射亲代脾细胞后,其体内肿瘤的存在会部分抑制移植物抗宿主反应。
Br J Cancer. 1981 Mar;43(3):305-11. doi: 10.1038/bjc.1981.48.
3
Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth.
随着MOPC - 315浆细胞瘤肿瘤生长进展,美法仑治疗效果增强。
Cancer Immunol Immunother. 1983;15(2):101-7. doi: 10.1007/BF00199699.